VAERS reports by lot

GSK Varicella/Shingles lot 4NX5J: VAERS reports

22 VAERS reports list lot 4NX5J as a GSK Varicella/Shingles vaccine, received between 2022-03-09 and 2022-10-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
14%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1723%
General / Systemic (non-local)1318%
Neurological1115%
Dermatological (non-injection-site)1014%
Gastrointestinal710%
Musculoskeletal68%
Cardiac / Cardiovascular45%
Allergic / Anaphylactic45%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New Jersey3
Alabama3
New York2
North Carolina2
Indiana2
Ohio2
California2
Virginia1
Washington1
Nevada1
Kansas1
Michigan1

Reports by month received

2022-033
2022-046
2022-055
2022-062
2022-071
2022-083
2022-102

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.